- ISIN
- US53228F1012
- CUSIP
- 53228F101
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- IPO Date
- Jun 10, 2021
Highlights
- Market Cap
- $4.06B
- Enterprise Value
- $4.11B
- EPS (TTM)
- $0.06
- PE Ratio
- 176.97
- PEG Ratio
- 1.82
- Total Revenue (TTM)
- $1.49B
- Gross Profit (TTM)
- $323.87M
- EBITDA (TTM)
- $83.67M
- Year Range
- $3.79 - $11.76
- Target Price
- $9.30
- ROA (TTM)
- 1.08%
- ROE (TTM)
- 1.57%
- Avg. Volume (1M)
- 3M
- Avg. Volume Value (1M)
- $33.60M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
LFST Performance Chart
LifeStance Health Group, Inc. (LFST) is up 48.9% since the beginning of the year. At $10 per share, LFST is trading 10.9% below its 52-week high of $12. Investors who bought $1,000 worth of LFST shares 5 years ago would now be looking at an investment worth $442.
Loading charts...
Compare this symbol against anything
Returns By Period
LifeStance Health Group, Inc. (LFST) has returned 48.86% so far this year and 176.52% over the past 12 months.
LifeStance Health Group, Inc.
- 1D
- -2.42%
- 1M
- -7.01%
- 6M
- 48.23%
- YTD
- 48.86%
- 1Y
- 176.52%
- 3Y*
- 3.80%
- 5Y*
- -15.06%
- 10Y*
- —
- ALL TIME*
- -11.82%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
LFST Monthly Returns History
Based on dividend-adjusted daily data since Jun 10, 2021, LFST's average daily return is +0.04%, while the average monthly return is +0.75%. At this rate, an investment would double in approximately 7.7 years.
Historically, 53% of months were positive and 47% were negative. The best month was Mar 2023 with a return of +45.1%, while the worst month was Aug 2021 at -37.3%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 6 months.
On a daily basis, LFST closed higher 49% of trading days. The best single day was Feb 28, 2024 with a return of +30.0%, while the worst single day was Aug 12, 2021 at -46.5%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.43% | 2.40% | -12.02% | 18.84% | 1.85% | 38.91% | -2.15% | 48.86% | |||||
| 2025 | 8.14% | -2.26% | -14.51% | -1.35% | -9.59% | -12.96% | -23.02% | 37.69% | 0.36% | -10.91% | 32.65% | 8.31% | -4.48% |
| 2024 | -23.63% | 39.63% | -26.11% | 0.16% | -9.87% | -11.85% | 12.22% | 14.52% | 10.94% | -4.14% | 12.07% | -1.99% | -5.87% |
| 2023 | 6.88% | -3.03% | 45.12% | 9.69% | 0.49% | 11.48% | 2.85% | -12.57% | -16.32% | -15.14% | 17.84% | 13.97% | 58.50% |
| 2022 | -19.85% | 23.59% | 7.21% | -33.04% | 10.04% | -25.37% | 7.19% | 5.54% | 5.25% | 14.05% | -32.58% | -2.95% | -48.11% |
| 2021 | 39.30% | -14.93% | -37.30% | -2.42% | -17.38% | -33.72% | 19.90% | -52.40% |
Benchmark Metrics
LifeStance Health Group, Inc. has an annualized alpha of -5.99%, beta of 1.34, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since June 10, 2021.
- This stock participated in 151.87% of S&P 500 Index downside but only 56.46% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -5.99%
- Beta
- 1.34
- R²
- 0.11
- Upside Capture
- 56.46%
- Downside Capture
- 151.87%
Return for Risk
Risk / Return Rank
LFST ranks 97 for risk / return — above 97% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for LifeStance Health Group, Inc. (LFST) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| LFST | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.53 | ||
| Sortino ratioReturn per unit of downside risk | +2.10 | ||
| Omega ratioGain probability vs. loss probability | 1.53 | 1.25 | +0.28 |
| Calmar ratioReturn relative to maximum drawdown | 9.63 | 2.00 | +7.63 |
| Martin ratioReturn relative to average drawdown | 21.98 | 8.49 | +13.49 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the LifeStance Health Group, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the LifeStance Health Group, Inc. was 86.91%, occurring on Aug 1, 2025. The portfolio has not yet recovered.
The current LifeStance Health Group, Inc. drawdown is 63.80%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-86.91%Aug 2025 | 4y 25d | — | 5y 27dJul 2021 - now | — |
-4.17%Jul 2021 | 2d | 5d | 7dJun 2021 - Jul 2021 | — |
-0.84%Jun 2021 | 1d | 1d | 1dJun 2021 - Jun 2021 | — |
-0.81%Jun 2021 | 1d | 4d | 4dJun 2021 - Jun 2021 | — |
Drawdown Indicators
| LFST | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.91% | -56.78% | -30.13% |
Max Drawdown (1Y)Largest decline over 1 year | -17.06% | -9.10% | -7.96% |
Max Drawdown (3Y)Largest decline over 3 years | -57.84% | -18.90% | -38.94% |
Max Drawdown (5Y)Largest decline over 5 years | -84.45% | -25.43% | -59.02% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -63.80% | -1.58% | -62.22% |
Average DrawdownAverage peak-to-trough decline | -72.49% | -10.70% | -61.79% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.47% | 2.14% | +5.33% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of LifeStance Health Group, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how LifeStance Health Group, Inc. is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for LFST, comparing it with other companies in the Medical Care Facilities industry. Currently, LFST has a P/E ratio of 177.0. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for LFST compared to other companies in the Medical Care Facilities industry. LFST currently has a PEG ratio of 1.8. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for LFST relative to other companies in the Medical Care Facilities industry. Currently, LFST has a P/S ratio of 2.7. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for LFST in comparison with other companies in the Medical Care Facilities industry. Currently, LFST has a P/B value of 2.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with LFST
Add LifeStance Health Group, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with LFST